Dr. Supratik Mukhopadhyay
Principal Investigator & Lead Researcher –Computer Science, Louisiana State University
Dr. Supratik Mukhopadhyay (PhD: Max Planck Institute for Informatics/University of Saarland) is an Associate Professor of Computer Science at Louisiana State University. His research interests include artificial intelligence and distributed computing. He has published over 100 research papers and has two awarded patents and one patent pending. His research has been funded by NSF, DOE, NASA, USDOT, ARO, ONR, NRL, DARPA, NGA, state agencies and industry. He has won numerous research awards. He has published in top journals and conferences that include Neural Networks, AAAI, ICRA, IROS, ACMTAAS, etc.
Dr. Michal Brylinski
Principal Investigator –Computational Biology, Louisiana State University
Dr. Michal Brylinski (PhD: Jagiellonian University) is an Associate Professor of the Department of Biological Science at Louisiana State University. His research interests include System Biology, Chemical Systems Biology and drug discovery and design.He has published over 80 papersand his research has been funded by NIH. Dr. Brylinski’s research incorporates multi-dimensional biological data into computer-aided drug discovery and design. He studies drug-oriented interactomes by combining high-level “omics” data, such as genomics, transcriptomics, proteomics, metabolomics, glycomics, and genome-wide association studies with molecular and atomic-level modeling of medically relevant biomolecules and interactions among them. He also applies deep learning technologies to integrate, analyze, and classify large-scale experimental and computer-generated biological data.
Dr. Tomislav Jelesijević
Principal Investigator –Virology –SARS COV, Iowa State University
Dr. Tomislav Jelesijević is an Assistant Professor at the Department of Veterinary Pathology, College of Veterinary Medicine, Iowa State University. He is a Doctor of Veterinary Medicine with an ACVP board certification in anatomic pathology, a PhD in virology (SARS Corona Virus), and post-doctoral experience in bacteriology & vaccine development. Dr. Jelesijević has ten years of Biosafety Level 3 (BSL-3) accident-free select agent work on SARS Corona Virus, Burkholderia mallei, Burkholderia pseuodmallei, and Mycobacterium tuberculosis often applied in various animal models, including nonhuman primates.